Asian Spectator

Times Advertising

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Tes jenis kelamin atlet untuk melarang trasgender justru berisiko menggagalkan perempuan interseks ikut olimpiade

Tes jenis kelamin di olahraga elite memiliki sejarah panjang yang tidak konsisten.anton5146/iStock via Getty Images PlusPada 26 Maret 2026, Komite Olimpiade Internasional (IOC) mengumumkan kebijakan b...

Loker di Indonesia: Perusahaan khawatir Gen Z lembek, tapi enggan rekrut senior yang tahan banting

● Kondisi ketenagakerjaan nasional berada dalam tahap yang memprihatinkan sejak lama.● Para pemberi kerja enggan merekrut Gen Z, tapi juga emoh merekrut pekerja dari generasi senior.●...

Angka deforestasi meningkat, bayang-bayang krisis dan bencana mengintai

● Deforestasi Indonesia meningkat tajam, terjadi di semua pulau besar, terutama Kalimantan dan Papua.● Lonjakan ekstrem turut terjadi di Aceh, Sumatera Utara, dan Sumatera Barat, berkorela...